This is a standard earnings date announcement with no market-moving content. Monitor the Q2 2026 earnings release on July 30 for revenue and EPS trends relative to consensus, particularly given Labcorp's exposure to diagnostic testing volume trends and pharma end-market demand.
LH drugs
LH drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jul 1 $283.88entry
- T+1 · 5mo ago +1.09%α +1.22% · $286.98
- T+5 · 4mo ago −0.01%α −0.27% · $283.86
- T+20 · 4mo ago +8.20%α +10.38% · $307.15
- T+60 · 8w ago +8.83%α +5.96% · $308.95
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Labcorp filed a routine 8-K announcing the date of its Q2 2026 earnings release and conference call. The filing contains no financial results, guidance, or material business developments, it is an administrative scheduling notice.
Key Facts
- Q2 2026 earnings will be released before market open on July 30, 2026
- Conference call and webcast scheduled for 9:00 AM ET on July 30, 2026
- No preliminary financial results, forward guidance, or strategic updates were disclosed
- Earnings materials will be posted on Labcorp's investor relations website
Financial Impact
No financial data provided in this filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0000920148-26-000150 |
| Document: formpr2q26ex991earningsann.htm | 0000920148-26-000150 |
| Document: 0000920148-26-000150-index-headers.html | 0000920148-26-000150 |
| Document: 0000920148-26-000150-index.html | 0000920148-26-000150 |
| Document: 0000920148-26-000150.txt | 0000920148-26-000150 |
Track record
29 reports on LH
5 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +17.60% at T+60 after the Apr 30, 2026 report. 5 of 5 went positive at some point.
Filters
- Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $372.32 Now $372.46 +0.04% settles Nov 19
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $372.23 Now $372.46 +0.06% settles Nov 18
- Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $363.30 to $372.32 Now $372.46 +2.52% ▲ +2.48% −0.81% vs SPY
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $367.79 to $372.23 Now $372.46 +1.27% ▲ +1.21% +2.12% vs SPY
- Nov 4, 202612d ago 8-K Neutral 2/10 Entry $367.79 to $372.23 Now $372.46 +1.27% ▲ +1.21% +2.12% vs SPY
- Nov 3, 202613d ago 144 Neutral 2/10 Entry $353.92 to $370.88 Now $372.46 +5.24% ▲ +4.79% +5.38% vs SPY
- Oct 30, 202617d ago 144 Neutral 2/10 Entry $361.39 to $366.57 Now $372.46 +3.06% ▲ +1.43% +4.14% vs SPY
- Oct 28, 202619d ago 8-K Bullish 6/10 Entry $360.25 to $367.79 Now $372.46 +3.39% ▲ +2.09% +2.81% vs SPY
- Oct 26, 202621d ago Institutional Cluster Neutral 3/10 Entry $329.90 to $361.39 Now $372.46 +12.90% ▲ +9.55% +10.81% vs SPY
- Oct 21, 202626d ago 8-K Neutral 2/10 Entry $323.75 to $331.17 Now $372.46 +15.05% ▲ +2.29% +2.74% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers